17Q1.F PHARMARON BEIJING H YC1

Healthcare Oil, Gas & Consumable Fuels Frankfurt Exchange
17.25 EUR
Close of Nov 11, 2026
1.58 3.70
Market cap
EUR 6.21B
P/E
28.2x
P/B
2.75x
ROE
9.8%
Dividend yield
0.76%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 17Q1.F undervalued?

Graham number
Price17.25
Graham value9.29
Premium85.7%

17Q1.F trades 85.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PHARMARON BEIJING H YC1 fundamental analysis

No fundamental analysis for PHARMARON BEIJING H YC1 yet.

PHARMARON BEIJING H YC1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PHARMARON BEIJING H YC1

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological …

Full company profile